Search research articles
Contact Us
Filters
Showing results (211-220 of 522) with videos related to
Page
of 53
Sort By:
Plos One
|
October 4, 2016
Synthesis, Pharmacological Profile and Docking Studies of New Sulfonamides Designed as Phosphodiesterase-4 Inhibitors
Isabelle Karine da Costa Nunes, Everton Tenório de Souza, Suzana Vanessa S Cardozo, et al.
European Journal of Medicinal Chemistry
|
June 1, 2012
Docking, synthesis and pharmacological activity of novel urea-derivatives designed as p38 MAPK inhibitors
Raquel de Oliveira Lopes, Nelilma Correia Romeiro, Cleverton Kleiton F de Lima, et al.
Current Topics in Medicinal Chemistry
|
November 22, 2012
Docking, synthesis and anti-diabetic activity of novel sulfonylhydrazone derivatives designed as PPAR-gamma agonists
Gisele Zapata-Sudo, Lídia M Lima, Sharlene L Pereira, et al.
The Annals of Thoracic Surgery
|
May 30, 2006
Valproic acid prevents brain injury in a canine model of hypothermic circulatory arrest: a promising new approach to neuroprotection during cardiac surgery
Jason A Williams, Christopher J Barreiro, Lois U Nwakanma, et al.
The Annals of Thoracic Surgery
|
May 26, 2009
Inspiring medical students to pursue surgical careers: outcomes from our cardiothoracic surgery research program
Jeremiah G Allen, Eric S Weiss, Nishant D Patel, et al.
Bioorganic & Medicinal Chemistry
|
April 3, 2003
Antiplatelet properties of novel N-substituted-phenyl-1,2,3-triazole-4-acylhydrazone derivatives
Anna C Cunha, Juliana M Figueiredo, Jorge L M Tributino, et al.
Chemical Biology & Drug Design
|
August 18, 2017
Discovery of naphthyl-N-acylhydrazone p38α MAPK inhibitors with in vivo anti-inflammatory and anti-TNF-α activity
Rosana H C N Freitas, Natália M Cordeiro, Patrícia R Carvalho, et al.
Drug Design, Development and Therapy
|
September 28, 2016
Synthesis, solubility, plasma stability, and pharmacological evaluation of novel sulfonylhydrazones designed as anti-diabetic agents
Gisele Zapata-Sudo, Isabelle Karine da Costa Nunes, Josenildo Segundo Chaves Araujo, et al.
European Journal of Medicinal Chemistry
|
June 9, 2009
Studies towards the identification of putative bioactive conformation of potent vasodilator arylidene N-acylhydrazone derivatives
Arthur E Kümmerle, Juliana M Raimundo, Carla M Leal, et al.
Plos One
|
March 12, 2014
Docking, synthesis and antiproliferative activity of N-acylhydrazone derivatives designed as combretastatin A4 analogues
Daniel Nascimento do Amaral, Bruno C Cavalcanti, Daniel P Bezerra, et al.
Page
of 53
Search research articles
Search
Showing results (211-220 of 522) with videos related to
Sort By:
Page
of 53
Plos One
|
October 4, 2016
Synthesis, Pharmacological Profile and Docking Studies of New Sulfonamides Designed as Phosphodiesterase-4 Inhibitors
Isabelle Karine da Costa Nunes, Everton Tenório de Souza, Suzana Vanessa S Cardozo, et al.
European Journal of Medicinal Chemistry
|
June 1, 2012
Docking, synthesis and pharmacological activity of novel urea-derivatives designed as p38 MAPK inhibitors
Raquel de Oliveira Lopes, Nelilma Correia Romeiro, Cleverton Kleiton F de Lima, et al.
Current Topics in Medicinal Chemistry
|
November 22, 2012
Docking, synthesis and anti-diabetic activity of novel sulfonylhydrazone derivatives designed as PPAR-gamma agonists
Gisele Zapata-Sudo, Lídia M Lima, Sharlene L Pereira, et al.
The Annals of Thoracic Surgery
|
May 30, 2006
Valproic acid prevents brain injury in a canine model of hypothermic circulatory arrest: a promising new approach to neuroprotection during cardiac surgery
Jason A Williams, Christopher J Barreiro, Lois U Nwakanma, et al.
The Annals of Thoracic Surgery
|
May 26, 2009
Inspiring medical students to pursue surgical careers: outcomes from our cardiothoracic surgery research program
Jeremiah G Allen, Eric S Weiss, Nishant D Patel, et al.
Bioorganic & Medicinal Chemistry
|
April 3, 2003
Antiplatelet properties of novel N-substituted-phenyl-1,2,3-triazole-4-acylhydrazone derivatives
Anna C Cunha, Juliana M Figueiredo, Jorge L M Tributino, et al.
Chemical Biology & Drug Design
|
August 18, 2017
Discovery of naphthyl-N-acylhydrazone p38α MAPK inhibitors with in vivo anti-inflammatory and anti-TNF-α activity
Rosana H C N Freitas, Natália M Cordeiro, Patrícia R Carvalho, et al.
Drug Design, Development and Therapy
|
September 28, 2016
Synthesis, solubility, plasma stability, and pharmacological evaluation of novel sulfonylhydrazones designed as anti-diabetic agents
Gisele Zapata-Sudo, Isabelle Karine da Costa Nunes, Josenildo Segundo Chaves Araujo, et al.
European Journal of Medicinal Chemistry
|
June 9, 2009
Studies towards the identification of putative bioactive conformation of potent vasodilator arylidene N-acylhydrazone derivatives
Arthur E Kümmerle, Juliana M Raimundo, Carla M Leal, et al.
Plos One
|
March 12, 2014
Docking, synthesis and antiproliferative activity of N-acylhydrazone derivatives designed as combretastatin A4 analogues
Daniel Nascimento do Amaral, Bruno C Cavalcanti, Daniel P Bezerra, et al.
Page
of 53